Dianthus Therapeutics (DNTH) Other Non-Current Assets (2017 - 2025)
Dianthus Therapeutics' (DNTH) quarterly Other Non-Current Assets came in at $9.7 million in Q4 2025, up 0.9% year-on-year from $9.6 million in Q4 2024, and up 5717.96% quarter-over-quarter from $167000.0 in Q3 2025.
Dianthus Therapeutics (DNTH) Other Non-Current Assets (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $9.7 million for Q4 2025.
- On a quarterly basis, Other Non-Current Assets rose 0.9% year-over-year to $9.7 million in Q4 2025; TTM through Dec 2025 was $9.7 million, a 0.9% increase from a year earlier, with the FY2025 full-year figure at $9.7 million, up 0.9% from the prior year.
- Other Non-Current Assets rose to $9.7 million in Q4 2025 per DNTH's latest filing, from $167000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $9.7 million in Q4 2025 and bottomed at $60000.0 in Q3 2022.
- The 5-year median for Other Non-Current Assets is $230000.0 (2024), against an average of $2.0 million.
- Across the five-year window, Other Non-Current Assets sank 96.63% in 2022 and soared 14489.39% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $1.8 million in 2021, then plunged by 96.63% to $60000.0 in 2022, then grew by 10.0% to $66000.0 in 2023, then surged by 14489.39% to $9.6 million in 2024, then advanced by 0.9% to $9.7 million in 2025.
- Per Business Quant, the three latest DNTH Other Non-Current Assets figures stand at $9.7 million (Q4 2025), $167000.0 (Q3 2025), and $9.2 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Dianthus Therapeutics | 3.37 Bn | 2.97 Bn | - | 9.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.72 Mn |
| Sep 30, 2025 | 167,000.00 |
| Jun 30, 2025 | 9.18 Mn |
| Mar 31, 2025 | 231,000.00 |
| Dec 31, 2024 | 9.63 Mn |
| Sep 30, 2024 | 229,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Mar 31, 2024 | 66,000.00 |
| Dec 31, 2023 | 66,000.00 |
| Sep 30, 2023 | 65,000.00 |
| Jun 30, 2023 | 125,000.00 |
| Mar 31, 2023 | 60,000.00 |
| Dec 31, 2022 | 60,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 1.78 Mn |
| Mar 31, 2022 | 1.78 Mn |
| Dec 31, 2021 | 1.78 Mn |
| Sep 30, 2021 | 1.78 Mn |
| Jun 30, 2021 | 1.78 Mn |
| Mar 31, 2021 | 1.78 Mn |